Date:03-May-2024  Time: 8:28 PM
 
 
        
Beryl Drugs Ltd
Quarters:       (Rs. In Crores)
ParticularsDec 2023Sep 2023Jun 2023Mar 2023
Type3Qtr2Qtr1Qtr4Qtr
Net Sales7.628.038.116.11
Other Income0.000.000.000.00
Total Income7.668.098.176.09
Total Expenditure 6.867.377.045.82
Operating Profit0.800.721.130.27
Interest0.110.100.120.06
Gross Profit0.680.621.010.21
Depreciation0.310.290.280.15
Tax0.110.160.240.01
Deferred Tax-0.05-0.10-0.04-0.02
Reported Profit After Tax0.310.270.530.06
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com